Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0294 | 0.8165 | 0.8165 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0055 | 0 | 0.5 |
Brugia malayi | Sema domain containing protein | 0.0123 | 0.2331 | 0.2331 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0055 | 0 | 0.5 |
Echinococcus multilocularis | plexin a4 | 0.0348 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Echinococcus granulosus | plexin a4 | 0.0348 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0123 | 0.2331 | 0.2331 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0055 | 0 | 0.5 |
Onchocerca volvulus | 0.0294 | 0.8165 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.3978 | 0.3978 |
Brugia malayi | Sema domain containing protein | 0.0123 | 0.2331 | 0.2331 |
Schistosoma mansoni | plexin | 0.0171 | 0.3978 | 0.2822 |
Trypanosoma brucei | cytochrome P450, putative | 0.0055 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0068 | 0.0469 | 0.5 |
Loa Loa (eye worm) | plexin A | 0.0348 | 1 | 1 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0068 | 0.0469 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Leishmania major | cytochrome p450-like protein | 0.0055 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.3978 | 0.2822 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Brugia malayi | Plexin repeat family protein | 0.0294 | 0.8165 | 0.8165 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2331 | 0.2331 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0123 | 0.2331 | 0.2331 |
Schistosoma mansoni | plexin | 0.0294 | 0.8165 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Bapp (binding) | = 0.055 | Apparent number of binding sites per base pairs in DNA | ChEMBL. | 6169834 |
Delta Tm (ADMET) | = 5.8 | Thermal denaturation (deltaTm) of compound against calf thymus DNA was measured | ChEMBL. | 6169834 |
ED50 (functional) | = 0.81 uM | Concentration required for 50% inhibition of incorporation of labeled uridine by P388 cells for the synthesis of RNA (in vitro) | ChEMBL. | 6169834 |
ED50 (functional) | = 0.81 uM | Concentration required for 50% inhibition of incorporation of labeled uridine by P388 cells for the synthesis of RNA (in vitro) | ChEMBL. | 6169834 |
ED50 (functional) | = 2.45 uM | Concentration required for 50% inhibition of incorporation of labeled thymidine by p388 cells for synthesis of DNA (in vitro) | ChEMBL. | 6169834 |
ED50 (functional) | = 2.45 uM | Concentration required for 50% inhibition of incorporation of labeled thymidine by p388 cells for synthesis of DNA (in vitro) | ChEMBL. | 6169834 |
K app (binding) | = 3800000 M-1 | Apparent binding constant calf thymus DNA-drug complex | ChEMBL. | 6169834 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.